More Bang For The Buck Needed In Pediatric Cardiac Device Development
This article was originally published in The Gray Sheet
Executive Summary
Despite recent attention to the matter by Congress, further incentives are needed to induce development of pediatric devices, physicians say
You may also be interested in...
Pediatric Device Developers Counting On Easier Path To Market
Developing medical technologies exclusively for children has not typically been an easy or profitable path to tread
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.